At European CLL Association (ECLLA), our mission is clear: to improve outcomes for people living with Chronic Lymphocytic Leukemia (CLL) across the geographic region of Europe. CLL is the most common adult leukemia, yet access to diagnosis, treatment, supportive care, and information continues to vary significantly between countries. ECLLA was established to help address these disparities by strengthening collaboration and building a unified European voice for the CLL community.
ECLLA brings together patient organizations, clinicians, researchers, and partners from across Europe. By connecting expertise and lived experience, we aim to foster meaningful cooperation that accelerates progress in research, improves standards of care, and ensures that patient perspectives are central to decision-making. Our approach is grounded in partnership—recognizing that sustainable change in CLL care can only be achieved when stakeholders work together across borders and disciplines.
A core focus of ECLLA’s work is equitable access to care. Innovations in CLL treatment and management have advanced rapidly in recent years, but not all patients benefit equally. Through advocacy, policy engagement, and evidence-informed dialogue, ECLLA seeks to highlight unmet needs and promote more consistent access to high-quality, patient-centred care throughout Europe.
In parallel, ECLLA is committed to advancing research and knowledge sharing. By supporting collaboration between researchers and clinicians, and by amplifying patient insights, we help create an environment where data, experience, and best practice can be shared more effectively. This collaborative model strengthens understanding of CLL and supports improvements not only in treatment, but also in long-term management and quality of life.
Ultimately, ECLLA exists to serve the CLL community. By uniting efforts at a European level, we aim to reduce inequalities, empower patients and patient organizations, and contribute to a future where everyone living with CLL—regardless of where they live—has access to informed, optimal, and equitable care.
ECLLA Team